ATE449094T1 - N-(pyridin-2-yl)sulfonamidderivate - Google Patents
N-(pyridin-2-yl)sulfonamidderivateInfo
- Publication number
- ATE449094T1 ATE449094T1 AT06765519T AT06765519T ATE449094T1 AT E449094 T1 ATE449094 T1 AT E449094T1 AT 06765519 T AT06765519 T AT 06765519T AT 06765519 T AT06765519 T AT 06765519T AT E449094 T1 ATE449094 T1 AT E449094T1
- Authority
- AT
- Austria
- Prior art keywords
- pyridine
- sulfonamide derivatives
- sulfonamide
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69135005P | 2005-06-16 | 2005-06-16 | |
US74877805P | 2005-12-09 | 2005-12-09 | |
PCT/IB2006/001581 WO2006134467A1 (en) | 2005-06-16 | 2006-06-06 | N-(pyridin-2-yl)-sulfonamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE449094T1 true ATE449094T1 (de) | 2009-12-15 |
Family
ID=36889285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06765519T ATE449094T1 (de) | 2005-06-16 | 2006-06-06 | N-(pyridin-2-yl)sulfonamidderivate |
Country Status (23)
Country | Link |
---|---|
US (1) | US7462634B2 (de) |
EP (1) | EP1893609B1 (de) |
JP (1) | JP4250675B2 (de) |
KR (1) | KR20080016649A (de) |
AR (1) | AR055060A1 (de) |
AT (1) | ATE449094T1 (de) |
AU (1) | AU2006257646A1 (de) |
BR (1) | BRPI0611853A2 (de) |
CA (1) | CA2610903A1 (de) |
DE (1) | DE602006010546D1 (de) |
EA (1) | EA200702498A1 (de) |
ES (1) | ES2334518T3 (de) |
GT (1) | GT200600258A (de) |
IL (1) | IL187695A0 (de) |
MA (1) | MA29550B1 (de) |
MX (1) | MX2007016319A (de) |
NL (1) | NL1031976C2 (de) |
NO (1) | NO20080164L (de) |
PE (1) | PE20070136A1 (de) |
TN (1) | TNSN07476A1 (de) |
TW (1) | TWI304062B (de) |
UY (1) | UY29606A1 (de) |
WO (1) | WO2006134467A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
EP2061767B1 (de) | 2006-08-08 | 2014-12-17 | Sanofi | Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung |
TW200827346A (en) | 2006-11-03 | 2008-07-01 | Astrazeneca Ab | Chemical compounds |
TW200836719A (en) | 2007-02-12 | 2008-09-16 | Astrazeneca Ab | Chemical compounds |
GB0705400D0 (en) | 2007-03-21 | 2007-05-02 | Univ Aberdeen | Therapeutic compounds andm their use |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
CN101990542A (zh) * | 2008-02-08 | 2011-03-23 | 德克萨斯大学董事会 | 环巴胺酒石酸盐及其用途 |
TW201014822A (en) | 2008-07-09 | 2010-04-16 | Sanofi Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
US20100022572A1 (en) | 2008-07-18 | 2010-01-28 | Kowa Company, Ltd. | Novel spiro compound and medicine comprising the same |
JP5574431B2 (ja) | 2008-08-29 | 2014-08-20 | 興和株式会社 | 1−アダマンチルアゼチジン−2−オン誘導体及びこれを含有する医薬 |
GB0817207D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | therapeutic apsac compounds and their use |
GB0817208D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | Therapeutic apsap compounds and their use |
JP5477973B2 (ja) | 2008-10-29 | 2014-04-23 | 興和株式会社 | 1,2−ジアゼチジン−3−オン誘導体及びこれを含有する医薬 |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
WO2011005505A2 (en) | 2009-06-22 | 2011-01-13 | Johnson Matthey Public Limited Company | Method for the purification of prostaglandins |
DK2470552T3 (en) | 2009-08-26 | 2014-02-17 | Sanofi Sa | NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
UA112418C2 (uk) | 2010-09-07 | 2016-09-12 | Астеллас Фарма Інк. | Терапевтичний болезаспокійливий засіб |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (de) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamidderivate als kinaseinhibitoren |
GB201311361D0 (en) | 2013-06-26 | 2013-08-14 | Pimco 2664 Ltd | Compounds and their therapeutic use |
ES2899852T3 (es) | 2014-12-17 | 2022-03-15 | Pimco 2664 Ltd | Compuestos de N-(4-hidroxi-4-metil-ciclohexil)-4-fenil-bencenosulfonamida y N-(-4-hidroxi-4-metil-ciclohexil)-4-(2-piridil)-bencenosulfonamida y su uso terapéutico |
EP3404020B1 (de) * | 2016-01-14 | 2022-11-30 | Research Cooperation Foundation of Yeungnam University | Pyridinolderivat oder pharmazeutisch unbedenkliches salz davon und pharmazeutische zusammensetzung damit als wirkstoff |
EP3235813A1 (de) | 2016-04-19 | 2017-10-25 | Cidqo 2012, S.L. | Aza-tetra-cyclo-derivate |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH570975A5 (de) | 1972-03-16 | 1975-12-31 | Ciba Geigy Ag | |
GB9409618D0 (en) * | 1994-05-13 | 1994-07-06 | Zeneca Ltd | Pyridine derivatives |
SE0001899D0 (sv) * | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
EP2399903A1 (de) * | 2002-05-24 | 2011-12-28 | Millennium Pharmaceuticals, Inc. | CCR9-Hemmer und Verwendungsverfahren dafür |
JP2007514731A (ja) * | 2003-12-19 | 2007-06-07 | ファイザー インコーポレイテッド | 糖尿病及び肥満症の治療のための11−ベータ−ヒドロキシステロイドデヒドロゲナーゼ1型(11−β−hsd−1)の阻害剤としてのベンゼンスルホニルアミノ−ピリジン−2−イル誘導体及び関連化合物 |
TWI380816B (zh) * | 2004-04-13 | 2013-01-01 | Synta Pharmaceuticals Corp | 抑制介白素-12(il-12)生成之二鹽抑制劑 |
US7429604B2 (en) * | 2004-06-15 | 2008-09-30 | Bristol Myers Squibb Company | Six-membered heterocycles useful as serine protease inhibitors |
FR2874011B1 (fr) | 2004-08-03 | 2007-06-15 | Sanofi Synthelabo | Derives de sulfonamides, leur preparation et leur application en therapeutique |
RU2416608C2 (ru) | 2004-08-06 | 2011-04-20 | Оцука Фармасьютикал Ко., Лтд. | Ароматическое соединение |
CA2579002C (en) * | 2004-09-02 | 2012-11-27 | Genentech, Inc. | Pyridyl inhibitors of hedgehog signalling |
WO2006034440A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
CN101035762B (zh) * | 2004-10-04 | 2010-09-29 | 霍夫曼-拉罗奇有限公司 | 用于糖尿病的作为11-β抑制剂的烷基(alkil)-吡啶类 |
-
2006
- 2006-06-06 BR BRPI0611853-4A patent/BRPI0611853A2/pt not_active IP Right Cessation
- 2006-06-06 AU AU2006257646A patent/AU2006257646A1/en not_active Abandoned
- 2006-06-06 KR KR1020077029384A patent/KR20080016649A/ko not_active Application Discontinuation
- 2006-06-06 MX MX2007016319A patent/MX2007016319A/es active IP Right Grant
- 2006-06-06 DE DE602006010546T patent/DE602006010546D1/de active Active
- 2006-06-06 WO PCT/IB2006/001581 patent/WO2006134467A1/en not_active Application Discontinuation
- 2006-06-06 EA EA200702498A patent/EA200702498A1/ru unknown
- 2006-06-06 AT AT06765519T patent/ATE449094T1/de not_active IP Right Cessation
- 2006-06-06 JP JP2008516436A patent/JP4250675B2/ja not_active Expired - Fee Related
- 2006-06-06 CA CA002610903A patent/CA2610903A1/en not_active Abandoned
- 2006-06-06 ES ES06765519T patent/ES2334518T3/es active Active
- 2006-06-06 EP EP06765519A patent/EP1893609B1/de active Active
- 2006-06-09 NL NL1031976A patent/NL1031976C2/nl not_active IP Right Cessation
- 2006-06-14 AR ARP060102523A patent/AR055060A1/es unknown
- 2006-06-15 GT GT200600258A patent/GT200600258A/es unknown
- 2006-06-15 US US11/455,065 patent/US7462634B2/en not_active Expired - Fee Related
- 2006-06-15 PE PE2006000672A patent/PE20070136A1/es not_active Application Discontinuation
- 2006-06-15 TW TW095121409A patent/TWI304062B/zh active
- 2006-06-16 UY UY29606A patent/UY29606A1/es not_active Application Discontinuation
-
2007
- 2007-11-27 IL IL187695A patent/IL187695A0/en unknown
- 2007-12-14 MA MA30483A patent/MA29550B1/fr unknown
- 2007-12-14 TN TNP2007000476A patent/TNSN07476A1/fr unknown
-
2008
- 2008-01-09 NO NO20080164A patent/NO20080164L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2007016319A (es) | 2008-03-10 |
ES2334518T3 (es) | 2010-03-11 |
JP4250675B2 (ja) | 2009-04-08 |
PE20070136A1 (es) | 2007-03-08 |
TW200736223A (en) | 2007-10-01 |
TNSN07476A1 (fr) | 2009-03-17 |
NO20080164L (no) | 2008-03-14 |
GT200600258A (es) | 2007-02-26 |
AU2006257646A1 (en) | 2006-12-21 |
NL1031976C2 (nl) | 2007-04-17 |
EP1893609B1 (de) | 2009-11-18 |
NL1031976A1 (nl) | 2006-12-19 |
JP2008543825A (ja) | 2008-12-04 |
TWI304062B (en) | 2008-12-11 |
CA2610903A1 (en) | 2006-12-21 |
EA200702498A1 (ru) | 2008-06-30 |
DE602006010546D1 (de) | 2009-12-31 |
EP1893609A1 (de) | 2008-03-05 |
US20070072914A1 (en) | 2007-03-29 |
IL187695A0 (en) | 2008-08-07 |
US7462634B2 (en) | 2008-12-09 |
WO2006134467A1 (en) | 2006-12-21 |
UY29606A1 (es) | 2007-01-31 |
BRPI0611853A2 (pt) | 2010-10-05 |
KR20080016649A (ko) | 2008-02-21 |
AR055060A1 (es) | 2007-08-01 |
MA29550B1 (fr) | 2008-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE449094T1 (de) | N-(pyridin-2-yl)sulfonamidderivate | |
DK1860941T3 (da) | Biphenyl-N-(4-pyridyl)methylsufonamider | |
DE602006010217D1 (de) | N piconets | |
ATE550315T1 (de) | Pestizid-bi-phenyl-amidin-derivate | |
IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
NL1030324A1 (nl) | Sulfonylbenzimidazoolderivaten. | |
ATE383361T1 (de) | Pyrrazolopyrimidinderivate | |
DK1919907T3 (da) | Heterocyklisk forbindelse | |
ATE415400T1 (de) | Pyrazolopyridinderivate | |
CR9080A (es) | Compuestos sulfonamida | |
DK1937650T3 (da) | Heterocykliske forbindelser | |
DE602006010581D1 (de) | 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate | |
DE602006009573D1 (de) | Vorspannungsschaltung | |
ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
ATE527255T1 (de) | Aryl-isoxazol-4-yl-imidazol-derivate | |
DE602005015729D1 (de) | Schreitroboter | |
DK1971588T3 (da) | Tiglien-3-onderivater | |
ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
ATE492529T1 (de) | Sulfonamidderivate | |
DE602005016309D1 (de) | Laas-bodeneinrichtungs-sigma-monitor | |
FR2881947B1 (fr) | Orthese reversible | |
ATE365731T1 (de) | 4-amino-5-cyanopyrimidinderivate | |
DE602006014973D1 (de) | Neuartige cercosporamidderivate | |
DK1928464T3 (da) | Ny parenteral carbamazepin-formulering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |